Target intelligence / Profile preview

Airway sensory nerve ending

Molecular classification
Other (collective term for sensory nerve structures; includes mechanoreceptors, chemoreceptors/nociceptors, but not a receptor, enzyme, ion channel, etc. itself)
01

Overview

Airway sensory nerve endings are specialized terminals of sensory neurons innervating the respiratory tract, primarily arising from the vagal and, to a lesser extent, dorsal root ganglia. These endings detect a wide array of mechanical and chemical stimuli and transmit signals to central nervous system circuits that regulate essential airway protective reflexes, including cough, bronchoconstriction, and respiration. Airway sensory nerves are heterogeneous, encompassing mechanoreceptors (Aδ fibers), chemoreceptors/nociceptors (C fibers), and others, each characterized by different conduction velocities, molecular markers, and functional responses. Pathological remodeling or sensitization of these nerve endings is implicated in airway diseases such as asthma and chronic cough. While not a molecular target in itself, the sensory nerve ending is a critical anatomical site for several emerging therapeutic strategies, including ion channel modulators, local anesthetics, and neuropeptide receptor antagonists

Other names
Airway sensory nerve terminalsAirway afferent nerve endingsAirway sensory nerve fibers
02

Mechanism of action

Desensitization or inhibition of sensory nerve endings to suppress pathological reflexes (e.g., cough suppression by P2X3 antagonists) Blockade of specific ion channels or receptors (e.g., TRPV1, P2X3, others) on sensory nerve endings Inhibition of neurogenic inflammation

03

Biological functions

Detection of chemical and mechanical stimuliReflex control of breathingRegulation of coughModulation of bronchoconstrictionImmune modulation through neuropeptide release
04

Disease associations

AsthmaChronic coughAirway inflammationAirway hyperreactivity
05

Safety considerations

Blocking sensory nerves may impair protective airway reflexes (risk of aspiration, infection)Modulation can affect airway tone or bronchoconstriction unpredictablyOff-target effects from agents affecting sensory neurons systemically
06

Interacting drugs

Capsaicin (experimental, activates nociceptive fibers)

5 more in the full profile.

07

Biomarkers

Nerve density in airway biopsies (experimental, linked to disease states)Neurotrophic factor levels (e.g., NGF in airway fluid, exploratory)No universally established biomarkers for direct patient selection

Beyond the preview

Go deeper on Airway sensory nerve ending.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Airway sensory nerve ending.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call